Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Petco Health and Wellness Company, Inc. (WOOF) SEC Filings & Earnings Calls

EquiReason read 17 Petco Health and Wellness Company, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-09-04 — Q3 FY2026 results: net sales flat, comparable sales +0.6%, net income up 177%, adjusted EBITDA +7.3%..

Source: SEC EDGAR filings · figures as of 2026-08-01 · read by EquiReason

WOOFPetco Health and Wellness Company, Inc.Follow WOOF — free
Specialty Retail · Consumer Cyclical
—
Price chart with a free account
Market cap
794.3M
P/E TTM
24.5
Dividend yield
—
52-week
—
Next earnings
23 Nov, in 30 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

4 Sep 202610-QQ3 FY2026 results: net sales flat, comparable sales +0.6%, net income up 177%, adjusted EBITDA +7.3%.earningsopen

Figures in the filing · each found in the filing text

Net sales · Q3-2026$1.49B+0% y/y
Comparable sales change · Q3-20260.6%
Adjusted EBITDA · Q3-2026$122M+7% y/y
Gross profit rate · Q3-202639.7%
Net income attributable to Class A and B-1 common stockholders · Q3-2026$39M+177% y/y
Free Cash Flow · H1-2026$61M+513% y/y
Operating cash flow · H1-2026$131M+85% y/y
Total pet care centers (U.S.) at end of period · Q3-20261,377-1% y/y
Net sales - Products · Products · Q3-2026$1.22B-1% y/y
Net sales - Services and other · Services and other · Q3-2026$272M+4% y/y

Risks flagged

Tariff and fuel cost pressure

“incremental cost pressures related to fuel and tariff expense during the thirteen weeks ended August 1, 2026” · word for word

Membership program disruption

“Sales during the thirteen weeks ended August 1, 2026 reflect a temporary disruption from a stronger-than-expected response to our membership program relaunch.” · word for word

Store count decline

“Total pet care centers (U.S.) at end of period 1,377 1,388” · word for word
Read the original on SEC EDGAR ↗
2 Sep 20268-K · 2.02, 7.01Q2 2026 net sales $1.5B (+0.05% YoY), comparable sales +0.6%, adjusted EBITDA $122.2M (vs $113.9M). Net income $38.7M (vs $14.0M). Reaffirmed FY2026 outlook. $75M debt prepaid.open

Figures in the filing · each found in the filing text

Net sales · Q2-2026$1.50B+0% y/y
Comparable sales · Q2-20260.6%
Gross profit · Q2-2026$591M+1% y/y
Gross margin rate · Q2-202639.7%
Operating income · Q2-2026$48M+11% y/y
Net income · Q2-2026$39M+176% y/y
Adjusted EBITDA · Q2-2026$122M+7% y/y
Cash, cash equivalents and restricted cash · Q2-2026$294M+56% y/y
Total debt · Q2-2026$1.48B-7% y/y

Guidance

FY2026 net sales flat to +1.5%, adjusted EBITDA $415M-$430M

FY2026 outlook reaffirmed; Q3 guidance provided with modest growth expectations.

Risks flagged

Sales disruption from membership program relaunch; initial stronger-than-expected points redemption.

“Sales disruption from the initial stronger-than-expected points redemption from our membership program relaunch” · word for word

Dependence on tariff refunds for margin improvement; normalized gross margin flat YoY.

“Without the net benefit from the tariff refund, normalized gross margin was about flat with the prior year” · word for word

Ongoing supply chain headwinds and tariff exposure.

“Absorbing ongoing supply chain headwinds; tariff refunds net benefit $6.8M”
Read the original on SEC EDGAR ↗
3 Aug 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)SEC ↗
17 Jul 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)SEC ↗
1 Jul 20268-K · 5.02, 5.07Reported the departure of a director or principal officer (CEO/CFO change); submitted matters to a vote of security holdersopen

Risks flagged

Potential dilution from increased authorized shares under equity incentive plan.

“Increase of 15.5 million shares of Class A common stock reserved for issuance under the 2021 Plan.”
Read the original on SEC EDGAR ↗
5 Jun 202610-QNet sales $1.50B (+0% y/y); Comparable sales change 0.7; Adjusted EBITDA $97M (+9% y/y)open

Figures in the filing · each found in the filing text

Net sales · Q1-2026$1.50B+0% y/y
Comparable sales change · Q1-20260.7%
Adjusted EBITDA · Q1-2026$97M+9% y/y
Gross profit rate · Q1-202638.4%
Free Cash Flow · Q1-2026$-69M-58% y/y
Services and other revenue · Services and other · Q1-2026$269M+7% y/y
Consumables revenue · Consumables · Q1-2026$747M-0% y/y
Supplies and companion animals revenue · Supplies and companion animals · Q1-2026$481M-3% y/y
Total pet care centers (U.S.) · Q1-20261,378-1% y/y

Risks flagged

Negative Free Cash Flow

“Free Cash Flow $(69,122) vs $(43,866)”

Inventory Build

“The decrease in operating cash flows were primarily driven by a increase in inventory purchases as well as timing of invoice payments.” · word for word

High Debt and Refinancing

“Loss on extinguishment and modification of debt $11.8 million; refinancing of term loan and issuance of $600M senior secured notes.” · word for word
Read the original on SEC EDGAR ↗
3 Jun 20268-K · 2.02, 7.01Net Sales $1.50B (+0% y/y); Comparable Sales 0.7; Gross Profit $574M; Guidance: Full-year net sales flat to up 1.5%; adjusted EBITDA $415-430M; Q2 net sales up ~0.3%.earningsopen

Figures in the filing · each found in the filing text

Net Sales · Q1-2026$1.50B+0% y/y
Comparable Sales · Q1-20260.7%
Gross Profit · Q1-2026$574M
Gross Margin · Q1-202638.4%
Operating Income · Q1-2026$25M+51% y/y
Adjusted EBITDA · Q1-2026$97M+9% y/y
Net Loss · Q1-2026$-15M
Total Debt · Q1-2026$1.48B-7% y/y
Free Cash Flow · Q1-2026$-69M

Guidance

Full-year net sales flat to up 1.5%; adjusted EBITDA $415-430M; Q2 net sales up ~0.3%.

Reaffirmed full-year outlook; Q1 results exceeded expectations; positive comp growth validates strategy.

Risks flagged

Free cash flow negative and worsening year-over-year; net loss increased.

“Free cash flow outflow of $69.1M vs $43.9M prior year; net loss of $15.1M vs $11.7M.”

Tariff and fuel cost uncertainties; partial tariff refund received but no additional assumed.

“Outlook assumes current tariff levels and elevated fuel prices; partial IEEPA tariff refund received in May 2026, no additional refunds assumed.”
Read the original on SEC EDGAR ↗
14 May 2026DEF 14APetco filed its proxy statement, disclosing executive compensation structure, incentive plan metrics, and a proposal to increase equity plan shares.open

Figures in the filing · each found in the filing text

Revenue · FY2025$5.96B
Adjusted EBITDA · FY2025$428M
Adjusted Free Cash Flow · FY2025$187M
Net Income · FY2025$9M
Total Shareholder Return · FY2025$10.33
Read the original on SEC EDGAR ↗
13 Mar 202610-KGoodwill Impairment Charge $1.22B; ABL Revolving Credit Facility Unused Commitments $468M; Principal Stockholder Voting Power 65open

Figures in the filing · each found in the filing text

Goodwill Impairment Charge · Q3 FY2023$1.22B
ABL Revolving Credit Facility Unused Commitments · 2026-01-31$468M
Principal Stockholder Voting Power · 2026-03-1365.0%

Risks flagged

Read the original on SEC EDGAR ↗
11 Mar 20268-K · 2.02, 7.01Net sales $6.00B (-2% y/y); Comparable sales -1.6; Gross profit $2.30B (-1% y/y); Guidance: FY2026 Adj. EBITDA $415M-$430M, net sales flat to +1.5%earningsopen

Figures in the filing · each found in the filing text

Net sales · FY2025$6.00B-3% y/y
Comparable sales · FY2025-1.6%
Gross profit · FY2025$2.30B-1% y/y
Gross margin · FY202538.7%
Operating income · FY2025$120M+1596% y/y
Net income · FY2025$9M
Adjusted EBITDA · FY2025$408M+21% y/y
Free cash flow · FY2025$187M+276% y/y
Cash from operations · FY2025$314M+77% y/y
Total secured debt · FY2025$1.50B-6% y/y

Guidance

FY2026 Adj. EBITDA $415M-$430M, net sales flat to +1.5%

FY2026 guidance implies return to positive comparable sales and continued margin expansion, with capex increasing to ~$140M for growth investments.

Risks flagged

Sales decline continues; comparable sales -1.6% for FY2025.

“Net sales decreased 2.5%; comparable sales decreased 1.6%.”

Tariff and fuel price assumptions in guidance could be disrupted.

“Assumptions include that current or planned tariffs on imports into the U.S. from other countries remain at March 11, 2026 levels and fuel prices normalize.”
Read the original on SEC EDGAR ↗
2 Feb 20268-K · 1.01, 2.03Petco entered into a $900M term loan refinancing and issued $600M in 8.250% senior secured notes due 2031 to repay existing term loan facility. The amendment increases leverage but extends maturities.open

Figures in the filing · each found in the filing text

aggregate principal amount of term loans · point_in_time$900M
aggregate principal amount of senior secured notes · point_in_time$600M
Read the original on SEC EDGAR ↗
2 Feb 20268-K · 5.02, 7.01Lump sum payment $9,615.38open

Figures in the filing · each found in the filing text

lump sum payment · point_in_time$9615.38
Read the original on SEC EDGAR ↗
23 Jan 20268-K · 7.01Principal amount of notes $600Mopen

Figures in the filing · each found in the filing text

Principal amount of notes$600M

Risks flagged

High coupon rate (8.250%) indicates elevated credit risk; refinancing may increase leverage.

“8.250% senior secured notes due 2031.” · word for word
Read the original on SEC EDGAR ↗
21 Jan 20268-K · 7.01Senior secured notes principal amount $650Mopen

Figures in the filing · each found in the filing text

Senior secured notes principal amount · point_in_time$650M

Risks flagged

Increased leverage from new notes; secured debt structure may subordinate existing unsecured creditors.

“The notes will be secured on a first-lien priority basis by security interests granted in Petco’s and the guarantors’ fixed assets and on a second-lien priority basis by security interests granted in Petco’s and the guarantors’ current assets.”
Read the original on SEC EDGAR ↗
12 Jan 20268-K · 7.01Adjusted EBITDA $396M; Guidance: FY2025 Net Sales down 2.5-2.8%, Adjusted EBITDA $395-$397M; Q4 Net Sales down low single digits, Adjusted EBITDA $93-$95Mopen

Figures in the filing · each found in the filing text

Adjusted EBITDA · FY2025$396M

Guidance

FY2025 Net Sales down 2.5-2.8%, Adjusted EBITDA $395-$397M; Q4 Net Sales down low single digits, Adjusted EBITDA $93-$95M

Petco reaffirms guidance with sales decline but stable EBITDA; debt refinancing aims to improve balance sheet.

Risks flagged

Debt refinancing subject to market conditions; may not be completed.

“Petco intends to refinance $1.5 billion of its current term loan outstanding subject to market and other conditions and therefore can provide no assurances that it will complete the refinancing” · word for word

Sales decline reflects consumer demand pressure and tariff risks.

“Net Sales Down 2.5% - 2.8%... assumptions include that... current or planned tariffs on imports into the U.S. from other countries remain at January 12, 2026 levels” · word for word
Read the original on SEC EDGAR ↗
5 Dec 202510-QPetco reported Q3 2025 results with net sales down 3.1% YoY but gross margin expansion and positive net income, without explicit beat/miss vs expectations.earningsopen

Figures in the filing · each found in the filing text

Net sales · Q3-2025$1.46B-3% y/y
Comparable sales change · Q3-2025-2.2%
Adjusted EBITDA · Q3-2025$99M+21% y/y
Net income (loss) attributable to Class A and B-1 common stockholders · Q3-2025$9M
Free Cash Flow · 39 weeks ended 2$71M
Operating cash flow · 39 weeks ended 2$161M+97% y/y
Gross profit rate · Q3-202538.9%

Risks flagged

Continued sales decline risk

“Net sales decreased $47.0 million, or 3.1%, to $1.46 billion in the thirteen weeks ended November 1, 2025 compared to net sales of $1.51 billion in the thirteen weeks ended November 2, 2024.” · word for word

Store count reduction risk

“Total pet care centers (U.S. and Puerto Rico) at end of period 1,389 compared to 1,413 in prior year.” · word for word
Read the original on SEC EDGAR ↗
25 Nov 20258-K · 2.02, 7.01Net sales $1.50B (-3% y/y); Comparable sales -2.2; Gross profit margin 38.9; Guidance: FY2025 adjusted EBITDA midpoint raised by $6M to $395-397M; Q4 adjusted EBITDA $93-95M.earningsopen

Figures in the filing · each found in the filing text

Net sales · Q3-2025$1.50B-3% y/y
Comparable sales · Q3-2025-2.2%
Gross profit margin · Q3-202538.9%
Operating income · Q3-2025$29M
GAAP net income · Q3-2025$9M
Adjusted EBITDA · Q3-2025$99M
Adjusted EBITDA guidance (FY2025) · FY2025$396M
Net interest expense guidance (FY2025) · FY2025$125M
Depreciation & Amortization guidance (FY2025) · FY2025$200M
Net store closures guidance (FY2025) · FY202520

Guidance

FY2025 adjusted EBITDA midpoint raised by $6M to $395-397M; Q4 adjusted EBITDA $93-95M.

Guidance raised on profitability despite sales decline; margin expansion driven by cost actions.

Risks flagged

Sales decline and store closures indicate ongoing transformation risk; tariff exposure noted in outlook assumptions.

“Net sales down 3.1% YoY; net store closures ~20; outlook assumes tariffs remain at current levels.”
Read the original on SEC EDGAR ↗

Petco Health and Wellness Company, Inc. — questions

What did Petco Health and Wellness Company, Inc. file recently?
17 SEC filings in the last 12 months. Latest: 10-Q on 2026-09-04 — Q3 FY2026 results: net sales flat, comparable sales +0.6%, net income up 177%, adjusted EBITDA +7.3%.

Every figure on this page comes from Petco Health and Wellness Company, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.